enzh-TWfrdeitjaptrues
You are here: Home Publications Pub-2013 Results of the phase II trial of single agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia

Results of the phase II trial of single agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenstrom macroglobulinemia


Can't see this document? Click Here

Legal | Privacy

Copyright © Bing Center for Waldenstrom's Macroglobulinemia 2000 - 2021